Letermovir prophylaxis and risk of bacterial or fungal infection after allogeneic hematopoietic cell transplantation
- 8 December 2025
- journal article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 32 (1) , 102888
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Risk-Adapted Letermovir Prophylaxis Based on a Scoring System Predicting a Higher Burden of Cytomegalovirus Exposure After Allogeneic Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2025
- Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infectionAnnals of Hematology, 2023
- Risk and Predictive Factors for Candidemia After Allogeneic Hematopoietic Cell Transplantation: JSTCT Transplant Complications Working GroupTransplantation and Cellular Therapy, 2022
- Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center StudyTransplantation and Cellular Therapy, 2022
- Cytomegalovirus reactivation is associated with an increased risk of late-onset invasive aspergillosis independently of grade II–IV acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: JSTCT Transplant Complications Working GroupAnnals of Hematology, 2021
- Prediction of Cytomegalovirus Reactivation by Recipient Cytomegalovirus-IgG Titer before Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2021
- Cytomegalovirus Reactivation Is Associated with Increased Risk of Late-Onset Invasive Fungal Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Study in the Current Era of Viral Load MonitoringTransplantation and Cellular Therapy, 2017
- Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working GroupTransplantation and Cellular Therapy, 2015
- Defining Incidence, Risk Factors, and Impact on Survival of Central Line-Associated Blood Stream Infections Following Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic SyndromeTransplantation and Cellular Therapy, 2013
- Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant ResearchTransplantation and Cellular Therapy, 2009